Increased ALK1 copy number and renal cell carcinoma - A case report

Virchows Archiv

Volumn 464, Issue 2, 2014, Pages 241-245

  Ryan, Ciara ^a   Mayer, Nick ^a   Cunningham, Joan ^b   Hislop, Gordon ^b   Pratt, Norman ^b   Fleming, Stewart ^b  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

ALK; Copy number; Renal cell carcinoma

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURGERY; CARCINOMA CELL; CASE REPORT; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; ENZYME ACTIVITY; GENE DOSAGE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; UPREGULATION; VARICOCELE;

ACTIVIN RECEPTORS, TYPE II; ADULT; CARCINOMA, RENAL CELL; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE;

EID: 84896719545     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1520-3     Document Type: Article

References (12)

1. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284
2. Mano H (2012) ALKoma: a cancer subtype with a shared target. Cancer discovery 2:495-502
3. Minoo P, Wang HY (2012) ALK-immunoreactive neoplasms. Int J Clin Exp Pathol 5:397-410
4. Lin E, Li L, Guan Y, Soriano R, Rivers CS, Mohan S, Pandita A, Tang J, Modrusan Z (2009) Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res 7:1466-1476
5. Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA (2011) Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 24:430-442
6. Marino-Enriquez A, Ou WB, Weldon CB, Fletcher JA, Perez-Atayde AR (2011) ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer 50:146-153
7. Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, Yuasa T, Yonese J, Kitagawa M, Mano H, Ishikawa Y, Takeuchi K (2012) Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer 118:4427-4436
8. Sukov WR, Hodge JC, Lohse CM, Akre MK, Leibovich BC, Thompson RH, Cheville JC (2012) ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol 25:1516-1525
9. Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, Zhou M, Argani P, Panel IRT (2013) The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 37:1469-1489
10. Ren H, Tan ZP, Zhu X, Crosby K, Haack H, Ren JM, Beausoleil S, Moritz A, Innocenti G, Rush J, Zhang Y, Zhou XM, Gu TL, Yang YF, Comb MJ (2012) Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer. Cancer Res 72:3312-3323
11. Bagci O, Tumer S, Olgun N, Altungoz O (2012) Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors. Cancer Lett 317:72-77
12. Rahilly MA, Fleming S (1992) A tumour promoter induces alterations in vinculin and actin distribution in human renal epithelium. J Pathol 166:283-288